Virtual Medicinal Product (VMP) - Atazanavir 300mg / Cobicistat 150mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Atazanavir 300mg / Cobicistat 150mg tablets | Start Date 17-08-2015 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- ATC Code
- J05AR15
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05030100 | Start Date 04-04-2022 | End Date |
| Previous BNF 05030100 | Start Date 23-05-2017 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 30251911000001101 | 17-08-2015 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Atazanavir sulfate | Based on Base Substance | Atazanavir | 300 mg | |
| Cobicistat | Based on Ingredient Substance | 150 mg |
Name
Atazanavir sulfate
Basis of strength description
Based on Base Substance
BOSS
Atazanavir
Strength and UOM (Nmr)
300
Strength and UOM (Dmr)
Name
Cobicistat
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
Parent Products
-
VTMAtazanavir + Cobicistat
-
VMP(Current) Atazanavir 300mg / Cobicistat 150mg ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |